BRITTANY HALL: Open Payments
NPI 1568759710 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 84 payments from 16 companies in 2025. Trend: 2023 $988 · 2024 $1,157 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $330 |
| Janssen Biotech, Inc. | 10 | $199 |
| Madrigal Pharmaceuticals | 6 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $106 |
| Gilead Sciences, Inc. | 5 | $97 |
| Celltrion USA Inc. | 3 | $81 |
| Ipsen Biopharmaceuticals, Inc | 4 | $68 |
| PFIZER INC. | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 9 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $60 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, XIFAXAN, LINZESS, VEGZELMA, DUPIXENT, IQIRVO.
Industry payments across LA — which companies pay providers there.
